DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
TSLIX
Price
$6.68
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
112.62M
Interact to see
Advertisement

DFSVX vs TSLIX

DFSVX vs TSLIX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. TSLIX commentary
Aug 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and TSLIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. TSLIX (113M). DFSVX pays higher dividends than TSLIX: DFSVX (1.50) vs TSLIX (0.79). DFSVX was incepted earlier than TSLIX: DFSVX (33 years) vs TSLIX (14 years). TSLIX (1.17) is less costly to investors than DFSVX (0.31). TSLIX is a more actively managed with annual turnover of: 27.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than TSLIX: DFSVX (0) vs TSLIX (1000000). TSLIX (35.72) and DFSVX (34.39) have marching annual gain over last year. DFSVX return over 5 years is better than : 50.66 vs. TSLIX (-45.36).
DFSVXTSLIXDFSVX / TSLIX
Total Expense Ratio0.310.9931%
Annual Report Gross Expense Ratio0.311.1726%
Fund Existence33 years14 years-
Gain YTD21.33625.32884%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B113M17,257%
Annual Yield % from dividends1.500.79189%
Returns for 1 year34.3935.7296%
Returns for 3 years50.3718.71269%
Returns for 5 years50.66-45.36-112%
Returns for 10 years107.71-28.91-373%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GXXIX14.420.14
+0.98%
abrdn US Sustainable Leaders InstlSvc
HISVX52.750.39
+0.74%
Harbor Small Cap Value Investor
AQEIX18.21-0.01
-0.05%
LKCM Aquinas Catholic Equity
IAXIX11.21-0.03
-0.27%
VY® T. Rowe Price Divers Mid Cap Gr I
PRHSX89.67-1.08
-1.19%
T. Rowe Price Health Sciences